Free Trial

Elanco Animal Health (ELAN) Stock Forecast & Price Target

$15.09
-0.26 (-1.69%)
(As of 09/6/2024 ET)

Elanco Animal Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 7 Wall Street analysts who have issued ratings for Elanco Animal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 1 has given a sell rating, 1 has given a hold rating, and 5 have given a buy rating for ELAN.

Consensus Price Target

$17.57
16.44% Upside
High Forecast$21.00
Average Forecast$17.57
Low Forecast$14.00

According to the 7 analysts' twelve-month price targets for Elanco Animal Health, the average price target is $17.57. The highest price target for ELAN is $21.00, while the lowest price target for ELAN is $14.00. The average price target represents a forecasted upside of 16.44% from the current price of $15.09.

TypeCurrent Forecast
9/8/23 to 9/7/24
1 Month Ago
8/9/23 to 8/8/24
3 Months Ago
6/10/23 to 6/9/24
1 Year Ago
9/8/22 to 9/8/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$17.57$17.57$18.29$15.10
Forecasted Upside16.44% Upside18.79% Upside18.45% Upside27.92% Upside
Get Elanco Animal Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.

ELAN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ELAN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Elanco Animal Health Stock vs. The Competition

TypeElanco Animal HealthMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.77
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside16.44% Upside1,207.55% Upside11.35% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/1/2024Piper Sandler
2 of 5 stars
 Lower TargetNeutral ➝ Neutral$19.00 ➝ $16.00+10.88%
6/28/2024Barclays
3 of 5 stars
 Lower TargetOverweight ➝ Overweight$23.00 ➝ $21.00+39.81%
2/27/2024The Goldman Sachs Group
2 of 5 stars
 Boost TargetSell ➝ Sell$12.50 ➝ $14.00-15.15%
2/27/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$16.00 ➝ $17.00+2.91%
1/5/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$13.00 ➝ $20.00+37.50%
12/19/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$17.00+24.45%
12/7/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$18.00+39.86%
11/8/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Vazquez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
10/17/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$24.00 ➝ $20.00+70.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:09 PM ET.

ELAN Forecast - Frequently Asked Questions

What is Elanco Animal Health's forecast for 2024?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Elanco Animal Health is $17.57, with a high forecast of $21.00 and a low forecast of $14.00.

Should I buy or sell Elanco Animal Health stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last year. There is currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ELAN shares.

Does Elanco Animal Health's stock price have much upside?

According to analysts, Elanco Animal Health's stock has a predicted upside of 18.79% based on their 12-month stock forecasts.

What analysts cover Elanco Animal Health?

Elanco Animal Health has been rated by research analysts at Barclays, and Piper Sandler in the past 90 days.

Do Wall Street analysts like Elanco Animal Health more than its competitors?

Analysts like Elanco Animal Health less than other "medical" companies. The consensus rating score for Elanco Animal Health is 2.57 while the average consensus rating score for "medical" companies is 2.77. Learn more on how ELAN compares to other companies.


This page (NYSE:ELAN) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners